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---Synopsis-------------------RADIOLOGY IN THE DIAGNOSIS OF CONGENITAL HEART
DISEASE
Howard C. Cameron, M.D.
U.W.O. Medical Jo~unal, March '51
The majority of congenital malformations may be differentiated by study of
information obtained on physical examination, electro-cardiograms, X-ray and a
fluoroscopic examination.
In a small percentage of cases, however, the more recent technique of angiocardiography and heart cathetrization are
proving to be valuable in diagnosing some
of the more difficult cases.
Fluoroscopy has more advantages than
X-ray in that it allows examination of
the patient in numerous positions and
brings to light any artefacts produced by
moving the heart and shoulders. Barium
swallows give an indication of the relationship of the esophagus and heart.

Various positions of examination gives
different information about the heart and
vessels:
1-the antero-posterior position 'bows
the size and shape of the heart and
great vessels,
2-the left anterior oblique positio.'l
shows the relative size of the ventricles,
3-the course of the aorta and the size
of the left auricle may be determined from the right anterior
oblique position .
The cardiac silhouette is considered to
be of little help in the infant.
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Office Procedure in the Diagnosis
of Hem.atologic Disorders
wr. BRUCE BARTON, M.D., F.R.C.P.(C).

INTRODUCTION
It is not generally appreciated that a practitioner, with a minimum of equipment, so me knowledge and a fair amo unt of patience can make in his office a
reasonably neat diagnosis of a blood dy scrasia . The categorization of abnormalities
of the peripheral blood is not strictly an exe rcise for a hospital laboratory, if a
few inexpensive tools and a kn owledge of how to use them are at hand.
This article wi ll make no attempt to classify abnormalities of th e hemopoietic system. Rath er, th e purpose is to draw to th e reader's attention some
basic facts, the appreciation of which may contribute towards making the practice of medicine a little less hum-drum and perhaps a little more exciting.
Furthermore, one may say that tr ea tm ent can sca rcely be rational wi thout a
precise di ag nosis. H ence the necessi ty for a definite diagnosis, if at all possi ble,
is self-evident. Poly pharmacy as it sta nds tod ay may seem superficially to have
simplified these problems but it has, in fact, introduced many new ones, for witho ut any id ea of the specificity of a response one may still be in doubt about the
exact nature of th e di sease which he is trea ting.

It is perhaps superfluous to mention
the importance of an adequate history,
but it is really a paramount essential. For
example, if one is dealing with an anemia,
he must know whether blood loss has
been occurring ; whether the diet has been
adequate; whether there may be associated infection, neoplasm , liver or kidney disease ; whether potentially harmful
drugs have been ing ested; whether a
harmful exposure to chemicals may have
occutred.
Physical examination is equally important. One seeks especially for enlarged lymph nodes, bone tenderness,
petechiae, or any peculiar skin lesions,
jaundice, enlargement of the liver and/or
spleen, and, of course, any other palpable
masses. The old dictum about the absolute crime of not inserting a finger into
the rectum may be mentioned here.
Actually the diagnosis of an hematologic disorder is most often , in the final
analysis, a laboratory procedure. One can
only make a presumptive diagnosis as a
M ARCH,
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rule, without laboratory aid. Herewith
then, will be descr ibed office laboratory
procedures which can be quite definite.

( 1) Hemoglobin Estimation
The methods which are used in the
office of a busy practitioner must of
necessity be simple and ideally not involve the fl.c quisition of expensive apparatus. Estimations of hemoglobin level
don e by the Tallqvist or Sahli method
are in such a category, but the important
feature to be remembered is that the range
of accu racy may be as poor as -+- 15 to
-1- 30 %.
Accordingly, a mild anemia
(10 .0 Gm .) may be read as 8.5 Gm.
(a fairly severe anemia) or as 11.5 G.m.
(a barely borderline anemia in the female) , using the Sahli method. If the
Tallqvist method is used a mild anemia
(10.0 Gm.) may be read as 13.0 Gm.
(normal in the female) or as 7.0 Gm . (a
severe anemia). Using the Spencer colorimetri c method a greater range of accuracy (-+- 5 to -+- 10 % ) rna y be obtained.
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---Diagnosis of Hematologic Disorders---------For the optimal accuracy photoelectric
methods must be employed. This apparatus may be temperamental and is subject
to error too, but a photoelectric machine
will deliver with an accuracy of -t-1 to
-+- 2o/o. The normal range of hemoglobin
is 12- 16 Gm. in the female, and 14- 18
Gm. in the male. This terminology is the
accepted and certainly the logical one at
the moment. Since the normal hemoglobin has a range it seems quite unscientific to select one value as representing 100% . In other words, anything between 14 and 18 Gm. in the male is 100%.
The reporting of hemoglobin in percentage, then, has little to recommend it,
and one rarely sees this done now.

(2) Red Cell Counts

in favor of the routine use of this test.
In addition, one can examine the color of
the plasma and make a rough estimate of
the level of white blood cells and platelets.
The normal range is 47.0 -+- 7.0% in the
male and 42.0 -+- 5.0% in the female.
( 4) White Cell Count
A white cell count is simply done and
can be done accurately if the minimum of
skill and care are used. This should be
looked upon as an essential part of a complete examination. The 110rmal range is 5,000
- 10,000 per m. mm.
( 5) Examination of a Smear of Peripheral Blood

These are mentioned simply to condemn
them . Such counts are most difficult to
do with a reproducible accuracy. To perform a guite accurate count, two pipettes
with balanced correction factors and two
counting chambers must be used. If inaccurate red cell counts ar·e used for the
calculation of indices (e.g. color index),
the error is compounded and the physician may be severely mislead, but there is,
of course, a real place for accurate red
cell counts on occasion. However, as an
office procedure they have nothing to
recommend them.

A drop of fresh blood (from the fingertip or ear lobe) evenly and thinly spread
on a clean glass slide (or preferably on
a clean cover glass) and well-stained, is
without doubt the most important single
test available for the assessment of the
status of the cellular components of the
blood. From it, one can gain information
on the character of the red cells-whether
they are normal in size and shape, whether
their hemoglobin content is normal and
whether immature forms are present. On
this observation depends mainly the selection of the proper agent for treatment.
If the red cells are small and pale, the
(3) Hematocrit (volume of packed red anemia is likely due to chronic blood loss.
Immediately, an explanation for this must
cells)
be sought. Ferrous sulfate by mouth will
It is unlikely that an adequate centriusually be effective, unless the blood loss
fuge will be available in the office of a
is very rapid or unless iron cannot be
practicing physician for the performance
absorbed from the gastro-intestinal tract.
of this test. The ordinary centrifuge
(This latter situation is a rare one inwhi ch is used for spinning urine must
deed.) If the red cells are large, the bone
never be used . A speed of somewhere bemarrow must be examined, for one may
tween 2500 and 3000 r.p.m. is necessary
be dealing with a liver principle defifor maximum packing of the red cells in
ciency anemia, in which case, the marrow
the Wintrobe hematocrit tube. These
will be megaloblastic. If the red cells are
speeds cannot be obtained except with
normal in size and shape and anemia is
centrifuges which are built for the job.
actually present a search must be conThe reproducible accuracy with which ducted for such things as chronic infechematocrits can be performed is greatly tion, uremia, acute blood loss, neoplasm,
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myxedema, etc. If immature forms are
present, causes of rapid blood formation
must be sought for . By immature red
cells one means nucleated forms , stippled
forms and large bluish-grey forms. These
last named cells are called polychromatophilic red cells and they are likely reticulocytes. In order to both identify these
cells as reticulocytes and to count them,
supravital stains may be used. This is not
as a rule an office procedure, but it could
be. The important thing to appreciate is
that the routine smear would give one a
lead toward further investigation which
can then be ordered for a legitimate
reason .
Red cells which are small and lack the
normal central zone of pallor are called
spherocytes. The finding of many of
these on smear may mean a hemolytic
anemia of either the acquired or congenital type. In the latter type they are
apt to be much more numerous. The
recognition of such cells then leads one
to rational additional investigation .
As well, one may gain information on
the leucocyte picture. A differential count
of at least one hundred white blood cells
will give the answer on ail abnormal
preponderance of any of the particular
types of leucocytes and, even ·more important, will give information on whether
or not any immaturity of granulocytes is
present. The presence of granulocytes
younger than the band or stab form must
never go unexplained. The differential
then , when paired with the total white
count, will be the deciding features, not
only in making a diagnosis of leukemia
but in categorizing it.
Also from the smear of peripheral
blood the adequacy of platelets may be
appraised. If many platelets are seen,
they can be said simply to be adequate
numerically. If they occur in clumps, it
is almost certain that their number is
normal. Occasionally giant forms are
seen . These are abnormal and may mean
a functional inadequacy. Platelet counts
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are difficult to do as an occasional procedure and are, of course, not to be recom mended as an office exercise. Clearly, if
their numbers are adequate on the smea r,
a count is quite superfluous.
( 6) Bleeding Time, Clotting Time,
Capillary Fragility
If the patient presents a problem in
abnormal bleeding, in addition to the
evaluation of platelets, the physician may
perform three simple tests - bleeding
time, clotting time and capillary fragility.
These, along with their rationale, have
been dealt with by Dr. Meltzer in a separate paper in this issue of the Journal.

(7) Sedimentation Rate
The sedimentation rate which is normally looked upon as an index of tissue
injury is increased actually because of an
elevation in plasma globulins and/or
plasma fibrinogen. Hence, it may be
applied to hematologic diseases which do
have changes in serum proteins. Striking
elevations of serum globulin are seen
usually in multiple myeloma (not a rare
disease if it is kept in mind!) and lesser
increases may be seen in Hodgkin's Disease and lymphocytic leukemia. Anemia
itself has some accelerating effect on the
fall of red cells, but if the Westergren
method (which is the common one) is
used, one does not need to correct for
the degree of anemia. If the Wintrobe
tube is used (and this is extremely convenient if a hematocrit is also going to
be performed) , correction curves have
been developed to adjust for the degree
of anemia. But it seems to be attempting
to introduce quite a degree of accuracy
into a crude test, and most authorities
will not bother with correcting for
anemia. At best, the erythrocyte sedimentation rate is only a screening test and
its non-specificity makes it of limited
value indeed in assessing the hematologic
status of the patient.
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---Diagnosis of Hematologic Disorders·---------(8) Bone Marrow Aspiration
The aspiration of bone marrow (fr~m
the sternum, iliac crests or poster~or
spinous processes) is clearly an offtee
procedure from the. technical ~oint of
view and it carries ltttle or no nsk. The
most important part of this procedure,
however, is the preparation of the smears
and their interpretation . These latter exercises require some experience, so I am
not in favor of bone marrow aspirations
being done by practitioners who are not
in a position to interpret what they see.
Furthermore, some help may be gained
from actually observing the events during the aspiration; the ease with which
the bone was penetrated; the occurrence
of suction pain ; the presence of "chunks"
of bone marrow in the aspirate. If the
person who is asked to make a diagnosis
has not performed the aspiration, I think
his position is a little more difficult: In
addition, it should be clearly appreCiated
that an appraisal of bone marrow aspirate
is in no way a substitute for meticulous
scanning of a film of peripheral blood.
These examinations are simply complementary. I know of no contra-indications
to bone marrow aspiration. One often
hears that this procedure must not be
done in the face of a bleeding tendency.
There is no added risk in a patient who
is bleeding, for most any bleeding from
a hole created by a # 18 needle can be
controlled by manual pressure for several
minutes.
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Conclusion
In conclusion it can be said that in
the past fifteen ~ears a consideraple body
of information has been accumulated relati.ng to the blood dyscrasias. The utilization· of these facts has removed therapy
from the metaphysical sphere and placed
it on a firm factual foundation. Not all
blood dyscrasias are amenable to specific
therapy for, very often, their etiology is
unknown; hence no specific therapy .is
available. Here such supportive measures
as blood transfusion may be quite justified ·and, indeed, may be the only therapeutic agent; but when a dyscrasia can. ~e
accurately categorized and a speof~c
agent is available· fQr its treatment,. thts
agent should be used, and preferably used
alone. The need for precise diagnosis is
surely obvious and it seems to me .that
the practicing physician should be tn a
position to make such a diagnosis. At
this point it might be justifiable to make
a plea for diagnosis before any therapy
is given, for often times after some treatment has been administered, even in small
amounts, a precise diagnosis is extremely
difficult or impossible.
With the above laboratory procedures
one can do a great deal toward making
a diagnosis of an abnormality of the
peripheral blood. The practicing physician will get a greater thrill out of his
labors and the patient will certainly benefit greatly, if the above-listed examination can be carried out and properly
interpreted.
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Leuketnia
Gerald T. Cook, Meds '56

INTRODUCTION
The most important single step in the diagnosis of leukemia is the microscopic examination of the stained blood film. The importance of this simple
routine laboratory procedure cannot be stressed too strongly . However, many of
these patients will be seen at a time when the hematologic findings do not give
an immediate and effortless diagnosis. It should be emphasized, therefore, that
these diseases are to be known by their entire natural history rather than by the
few facts concerning their clinical pathology.

Definition

Age and Sex Incidence

Leukerpia is a disease of unknown
etiology, which follows a progressive
course that is individually variable but
always fatal.

The acute and chronic forms of leukemia may occur in either sex at any
age . However, the maximum incidence is
shown below :

The acute and chronic forms of leukemia are distinguishable primarily by
their duration and the degree of immaturity of the predominating cells, the
acute form having the more rapid course
with its cells being the more immature.

Type
Acute leukemia
Chronic myelocytic
Chronic lymphocytic

Age
under 5 years
25 - 45 years
45- 60 years

Sex Incidence
1/1
M/F*

The leukemias are most conveniently
classified according to the predominating
types of cells.

M/F
M/F

:: 3/2
: : 3/1

"M/F-Male/Female Ratio

I. Chronic leukemia ·
a. Myelocytic
b. Lymphocyti.c
II. Acute leukemia
a. Myeloblastic
b. Lymphoblastic
c. Monocytic

The Nature of Leukemia
Leukemia is a disorderly, nonfunctioning overgrowth of myeloid or lymphoid
cells, that is invariably fatal, and in these
respects it resembles a malignant neoplasm.
A minority opinion is that it belongs
to the dim borderl-ine between inflammation and neoplasm.

MARcH, 1956

Pathology
The essential feature of leukemia is a
neoplastic proliferation of leukoblastic
tissue resulting in a great increase in the
white cells of the blood and cellular infiltration of organs. Occasionally, there
is a proliferation of white cells in the
tissue but they fail to appear in the blood
stream, a condition called "aleukemic
leukemia".
In chronic myelocytic leukemia there
is a myeloid hyperplasia which largely
crowds out the erythroblastic tissue. The
spleen becomes enormously enlarged and
firm, and may fill the entire abdomen .
The liver is moderately enlarged; lymph
nodes are usually normal in size.
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-----Leukemia----------------------------------------------In chronic lymphocytic leukemia the
lymph nodes all over the body are enlarged and their normal microscopic architecture is replaced by a diffuse mass of
lymphoid cells. Other lymphoid tissue is
similarly affected. The spleen is usually
moderately enlarged. The hyperplastic
bone marrow is composed largely of lymphoid cells.
In the acute forms, the infiltrating cells
are " blast" forms, but otherwise the infiltration in various tissues throughout
the body is similar to that observed in the
chronic leukemias. In addition, there is
anemia and a hemorrhagic tendency due
to thrombocytopenia.

CHRONIC MYELOCYTIC
LEUKEMIA
Clinical Features
The onset is insidious. Frequently the
initial complaints are weakness, pallor,
palpitation and dyspnea, which are attributable to the slowly advancing anemia.
There may be a fullness and dragging sensation in the abdomen due to the great
splenic enlargement. Fever, of intermittent or remittent type, may be an early
symptom. During acute exacerbations,
and as a late feature, hemorrhages may
occur under the skin, from the uterus,
kidneys, bowels, or into the retina or
mi ddle ear.
These symptoms . become more pronounced as the disease progresses.
Physical Examination
The general appearance of the patient
varies widely depending upon the severity
of anemia which is present.
1. Spleen is characteristically much en-

larged, extending across the midline
and reaching below the umbilicus.
2. Liver is usually palpable, and may
become enormous.
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3. Lymph nodes may occasionally be
slightly enlarged, but remain discrete.
4. There may be purpuric hemorrhages
under the skin.
5. As leukemic infiltrations may pres-

ent in almost any tissue of the body,
the pos5ible complications are many;
for example:
i) retinal hemorrhages and leukemic infiltrations.
ii) bluish grey, elevated nodules
in the skin.
iii) destruction of bone.
iv) deafness by hemorrhage or leukemic infiltration in the inner
or middle ears.
v) hemorrhages or tumor-like infiltrations in the central nervous system.
vi) hematuria.
vii) gastrointestinal
rhages.

tract

hemor-

Blood Examination
1. R.B.C. : There

IS a moderate but
slowly increasing anemia of normocytic and normochromic type; nucleated red cells may be found.

2. W .B.C.: Total count is 100,000 to
500,000 per cubic millimeter, or

more. The myelocyte is the predominant cell, but more primitive
forms are seen in the terminal stages
or in the blast crisis of leukemia.
3. Platelets: Most frequently there is
a slight increase in the blood platelets, or in some instances the numbers may be reduced to a marked
degree.

. If it is remembered that the white cell
count, the red cell count, and platelet
count may each approach · 1,000,000, some
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of the principal features of the blood picture may be recalled.
Prognosis
Spontaneous rem1ss1ons lasting from
months to years, have been reported, but
all cases are invariably fatal. About 50%
of chronic myelocytic leukemia patients
die in an acute phase. The mean survival
time is generally reported to be between
two and three years from the time of
diagnosis.

in

peri-

ii) marked anemia,
iv) failure to respond to roentgen
therapy.

CHRONIC LYMPHOCYTIC
LEUKEMIA

The onset is insidious. The clinical
manifestations of anemia-pallor, weakness, fatigue, dyspnea and palpitationsmay be the presenting symptoms. Frequently the patient observes a painless,
nontender lymph node in the neck, axilla
or groin. Less frequently, itchy red skin
caused by leukemic infiltration, or a hemorrhagic tendency may be the presenting
complaint.
Physical Examination
Again, the general appearance of the
patient depends upon the degree of anemia
which is present.
1. The lymph nodes of cervical, axil-
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3. The liver
enlarged.

is

usually

moderately

1. R.B.C.:

Anemia is not nearly as
marked as in chronic myelocytic
leukemia. But as the disease progresses, a normocytic, normochromic
anemia develops and becomes more
severe.

2. W.B.C. :

Clinical Features

MARCH,

spleen is most often palpable 7 to
8 em. below the left costal margin,

Blood Examination

iii) hemorrhages,

lary and inguinal regions are
frequently enlarged. They are
rubbery, discrete and painless.
nodes may attain the size of a

2. The firm non-tender edge of the

but never is a huge size attained.

The terminal stage is indicated by:
i) increased myeloblasts
pheral blood,

egg, and it is not uncommon to have
them spontaneously diminish in size.
The condition of the superficial
lymph nodes is not always a reliable
indication as to the presence or absence of general lymphoiJ hyperplasia, for the deep nodes ( abdominal and mediastinal) may be greatly
enlarged though the superficial ones
are barely palpable.

most
firm,
Some
hen's

Only the lymphoid cells
are increased, and may form as
much as 90 % of the average total
count of 50,000 to 100,000.

3. Platelets: The platelet count is characteristically moderately decreased,
but occasionally there is a great fall
or complete disappearance of platelets resulting in bleeding.
PROGNOSIS
The prognosis is better than in chronic
myelocytic leukemia. The average length
of life in patients with chronic lymphocytic leukemia is usually given as 3.5
years from the onset of symptoms. Some
live for 5 or 10 years and undoubtedly
a small percentage go into spontaneous
remission for several months or years, but
eventually the terminal stage of the disease is reached . About 15 % of chronic
lymphocytic leukemia patients die in an
acute phase.
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-----Leukemia--------------------------------------------ACUTE LEUKEMIA

TREATMENT OF LEUKEMIAS

Probably six types of acute leukemia
have been recognized, but for practical
purposes they may be considered as a
g roup, sin ce the clinical features and treatment are similar in all types. Frequently
the predominating type of primitive cell
ca nnot be positively identified .

Doubts are beginning to appear in the
minds of some authorities as to whether
treatment of the active case will actually
prolong life. However, statistics relating
to a large series of cases will never point
up the remarkable results which take
place occasionally in some individual
cases. It is generally accepted that specific therapy should be instituted when
definite symptoms appear or when the
disease enters a more active phase, and
not necessarily when the diagnosis is
made.

Clinical Features
Usually the clinical onset is abrupt, and
is often considered to be due to an upper
respiratory infection . There is fever, general malaise leading to prostration, and a
rapidly ad vancing anemia. Mainly because
of thrombocytopenia, epistaxis, spongy
bleeding gums, purpura and other hemorrhagic manifestations are common . Sore
throat and necrotic ulcers in the mouth
or pharynx are frequent. Lymph nodes
may be enlarged; the spleen and often
the liver are enlarged in terminal stages .
Blood Examination
1.

R .B.C. : There is almost always a
profound anemia, in which the total
red cells are 1,000,000 or less, per
cubi c millimeter.

2.

W .B.C.: The distinguishing feature
is the presence in the blood of a
large number of mononuclear, nong ranular primitive white cells. The
total count may be as low as 2,000,
but usually is increased lo 20,000
or 30,000.

3. Platelets : Thrombocytopenia is an
invariable feature, in fact, the platelets are virtually lacking.

Prognosis
The condition is invariably fatal, usually within eight weeks of onset. Occasion ally spontaneous remissions occur and
last up to six months, and in a few rare
cases, up to two years.
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Dr. Osgood's method of treating the
patient as soon as leukemia is diagnosed
using "titrated" P32 at regular intervals,
the dosage being governed by the induced response of the patient, has been
the object of much interest. Osgood reports mean survival time of slightly over
four years using "titrated" therapy, in
contrast to mean survival time of slightly
over two years using standard therapy.
Certainly therapy of chronic lymphocytic leukemia should be subtle and unobtrusive. This is particularly true in
asymptomatic cases in the older age group
discovered accidentally. Here no therapy
is by far the best therapy unless the disease gets out of hand. Then and only
then-and here Dr. Osgood disagreesshould therapy be instituted.

Treatment of Chronic Leukemia
It is most important that the differential diagnosis be accurate, because the
treatment of chronic forms is entirely different from that of the acute forms.

The treatment of chronic leukemia of
all types may be conveniently grouped
under radiation, chemical agents, and supportive measures.
1.

Radiation : Roentgen rays, radium,
radioactive isotopes may be used.

U.W.O.
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i) The use of roentgen rays is the
most satisfactory. X-rays may
be directed on a regional basis
to enlarged spleen or lymph
nodes, or by generalized "spray"
radiation. In chronic lymphocytic leukemia the localized
form of treatment is preferable. After a series of treatments, the leukocyte count may
fall to nearly normal, and further radiation may not be required for many months. As
time goes on, the intervals between treatments become shorter and eventually the condition
will become refractory and
death ensues.
Irradiation should not be used
in acute leukemia at any time.
It may be safely employed 10
"aleukemic" patients when the
leukocyte count is subnormal
in the beginning.
ii) Radioactive phosphorus is said
to be as effective as roentgen
radiation in the myelocytic type,
but less effective 1n lymphocytic leukemia. The radioactive
isotope P32 has a half-life of
about fourteen and one-half
days. It is given either by mouth
or· by injection and localizes in
the marrow, where overdoses
cause thrombocytopenia, leukopenia and anemia. If the
facilities are available, it is a
convenient method of treatment, and no irradiation sickness results. It is of no value
in acute leukemia.
2. Chemical Agents:

i) Ars.enic and benzene:
These have largely been replaced by newer, m~re effective agents.
ii) Urethane (ethyl carbamate):
Satisfactory and sometimes
MARCH,
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fairly long-lasting rem1sswns
can be induced in patients with
chronic myelocytic leukemia,
but it is of little benefit in the
treatment of chronic lymphocytic or acute leukemias. To be
effective, therapy with urethane
must be persevered. Enteric
coated tablets are often passed
unchanged; it is best given as
a syrup with meals, in dosage
of 2 to 4 grams. Urethane is
not generally used.
iii) Nitrogen mustard:
The use of nitrogen mustard
1s disappointing 10 the treatment of chronic leukemias. It
is of more use 1n treating
Hodgkin's disease.
iv) T.E.M. (triethylenemelamine):
T.E.M. is probably the treatment of choice in chronic lymphocytic leukemia. Since the response of the individual patient
varies tremendously, T.E.M.
must be cautiously instituted
with a single dose of 1 to 2
milligrams, and the hematological details be closely followed for two or three weeks.
Some patients have a marked
decrease in leukocyte count following the first dose. T.E.M.
is most suitable when the platelet · count is not depressed, because excessive doses cause
hemorrhagic tendencies due to
thrombocytopenia. It is of very
little value 10 chronic myelocytic leukemia, and 1n acute
leukemia.
v) Myleran:
This cytotoxic agent exerts a
retarding effect on any tissue,
but a relatively selective retardation of granulopoeisis. It
is effective in the treatment of
myelocytic leukemia. Given 10
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-----Leukemia--------------------------------------------oral daily doses of 4 milligrams, it produces general improvement in the patient's wellbeing, increase in appetite and
weight gain; definite reduction
in size of spleen and liver, as
well as decreased numbers of
granular leukocytes in peripheral blood. The number of
lymphocytes in peripheral blood
is not influenced. Myleran is
completely ineffective in acute
leukemia, chronic lymphocytic
leukemia, and chronic myelocytic leukemia during the outpouring of myeloblasts.
3.

St~pporl i t'e

Measures :

i) The prevention and treatment
of minor infections.
ii) Adequate nutrition and vitamins. Folic acid is definitely
contraindicated.
iii) Bed rest is indicated only until
there has been a remission of
fever . Otherwise patients may
be as active as their individual
capacities permit.

Probably treatment of patients with
acute leukemia does not result in any significant increase in life span after the
onset of symptoms. Nevertheless, moribund patients treated by modern methods
live to enjoy temporary improvement for
several weeks or months, and there is
always the hope and possibility that a
fairly long-lasting remission may be induced. A defeatist attitude must not be
assumed; these patients should be treated.
The three types of compounds that produce remissions in acute leukemia are folic
acid antagonists (aminopterin), 6-mercaptopurine, and ACTH or cortisone. With
any of these agents, relapse occurs and
drug resistance develops. However, an
infinitely better response is obtained in
the child patient than in the adult patient.
Best results are obtained in acute lymphoblasti< leukemia. In acute monoblastic
leukemia only supportive measures are of
any value.
1.

Aminopterin ( 4-aminopteroylglutamic
acid)
This is the most outstanding of
the folic acid antagonists advocated
for the control of acute lymphoblastic leukemia. In a few cases, dramatic improvements have resulted.
The drug is given orally in daily
doses ranging from 0.25 milligram
to 1 milligram for several days to
several weeks. Therapy IS discon tinued on resumption or normal
blood and marrow pictures, or the
development of toxic lesions which
consist of white, well-demarcated,
mucous-like patches and ulcers in
the soft tissues of the mouth and
intestinal tract.

2.

Cortisone and ACTH
These hormones have produced
dramatic temporary improvement.
If a remission can be produced with
cortisone and ACTH, it can often
be prolonged with 1 milligram of
aminopterin a day.

iv) Anemia: 1. The anemia associated with chronic myelocytic
leukemia almost uniformly improves when the leukemic process is under control. Transfusions are rarely required.
2. The acquired hemolytic
anemia associated with chronic
lymphocytic leukemia is best
treated with adrenal cortical
steroids.

Treatment of Acute Leukemia
The treatment of acute leukemia is so
different from that of chronic leukemias
that an accurate differentiation between
these two must be made before treatment
can be instituted . Roentgen therapy, radioactive phosphorus, and urethane do more
harm than good.
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3. 6-mercaptopurine
This anti-metabolite produces temporary remissions in young adults
suffering from acute leukemia. It
is given orally in daily doses of 2.5
milligram per kilogram of body
weight.
Recent reports suggest that in
children, therapy with cortisone
and aminopterin should be tried before 6-mercaptopurine.

If the patient is acutely ill, therapy
should be initiated with ACTH and cortisone since the antimetabolites require at
least three weeks to induce a remission.
Once a remission has been induced or the
acute emergency is passed, or if initially
the patient was not in a critical condition,
aminopterin (in young children) or 6mercaptopurine (in those over 10 years
of age) should be employed.

iii) Little or nothing can be done for
the severe thrombocytopenia and
hemorrhages that accompany the
disease.
Under therapy, many children can lead
happy lives for the duration of their illness, whereas the untreated patient may
suffer many painful complications.
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Agranulocytosis
Douglas 0. Manners, '56

INTRODUCTION
Agranulocytosis is a disorder of the blood characterized by a reduction in
the number of granulocytes and which may also include a decrease in the abso·
Jute number of other types of leukocytes .
The term agranulocytosis. as suggested by Schultz in 1922, described a clinical
entity that had previously been described by Brown in 1902 and Turk in 1907.
The clinical picture had been described in detail by Brown and Turk but general
interest had not been aroused until after Schultz presented six cases in 1922.
Since then a large number of cases have been described and a more complete
picture of the disease formed. Only in the more recent years has the relationship
between agranulocytosis and certain drug administration been clearly shown.
This condition has come to be known under many different names ; some of
these include: agranulocytic angina, granulocytopenia, granulopenia, agranulosis,
agranulocythemia, hypogranulocytosis, idiopathic, malignant or pernicious leukopenia and granulocytic hypoplasia.

ETIOLOGY AND INCIDENCE
The exact etiology is unknown . Agranulocytosis has been described in countries
throughout the world, but the majority
of the reported cases have been in the
United States and Germany. The disease
affects all classes with slightly increased
incidence among the medical profession,
including physicians, medical students and
nurses. The white race is seemingly much
more susceptible than the Negro population. The female rate is higher than the
male, in a ratio of 2 or 3 to 1. The peak
incidence occurs in the 35-45 year age
group.
The majority of cases are acute in character, although recurrent and chronic cases
have been described. Ther·e has been no
evidence of spread by contact and no
apparent seasonal incidence. Infection
often accompanies the picture of agranulocytosis and positive blood cultures of various organisms have been found. However, it is strongly felt that infection is
a secondary manifestation of the condition. Organisms cultured from the blood
have been injected into animals in an
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attempt to reproduce the disease, but without success.
The role of drugs as etiological factors
has been clearly shown by various investigators. Coal-tar derivatives, organic arsenicals and gold salts are among some
of the known agents. Agranulocytosis
has been produced only after prolonged
use of these drugs. The blood picture is
that of agranulocytosis and frequently
associated with thrombocytopenia and
anemia.
One of the greatest offenders is a drug
called amidopyrine ("Pyramidon"). It
was used extensively in Europe until 1933
in the treatment of arthritis. Cases have
been reported in which agranulocytosis
was produced after a single dose of this
drug and often proved fatal.
Other drugs causing agranulocytosis include dinitrophenol and certain sulfonamide compounds. The abnormal blood
picture may be transient but a decrease
in the number of granulocytes has been
clearly shown. The course of the drugs
is usually one of long term.
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Cases of agranulocytosis have been reported in people who have taken thiouracil in the treatment of hyperthyroidism;
tridione in the control of convulsions ;
certain antihistaminics (pyribenzamine and
methaphenilene) and chloramphenicol in
the treatment of pyogenic infections.
Within the past year, phenylbutazone
("Butazolidine") , used in the treatment
of arthritis, has been reported to cause
agranulocytosis . Recently, chlorpromazine
("Largactil") has been proven to cause a
few cases of agranulocytosis.
Several cases of idiopathic agranulocytosis have been reported without a history of drug therapy. A definite etiological agent might have been discovered
in some of these cases if the history and
investigation had been more thorough.
PATHOGENESIS
It has been suggested by Kracke that a
benzene ring with an attached "NH" or
"NH2" group produces an oxidation product which in turn produces a leukotoxic
effect. It has been postulated that these
toxic drugs may produce their effect by
interfering with certain enzyme systems
in the tissues.

In association with agranulocytosis, certain drugs frequently cause other signs
such as edema, rash, urticaria and an
asthmatic response. These manifestations
have suggested the possibility of an
allergic process. Tests to produce an antibody against amidopyrine in the hypersensitive individuals have been performed
with negative results. Scratch tests, patch
tests, intradermal tests and transfer tests
have been essentially non-contributory to
the theory of an allergic process.
The primary disturbance in the bone
marrow in agranulocytosis is a deficiency
of juvenile and segmented neutrophilic
leukocytes; thus, a "maturation arrest" beyond the stage of myeloblasts. However,
it is unlikely that this is the only factor
MARCH,
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because a leukopenia may develop within
six hours after a dose of amidopyrine.
Peripheral destruction of polymorphonuclear leukocytes or " pavementing" of leukocytes to the capillary endothelium must
be acting as well to produce the granulocytic deficiency. Thus, the exact mechanism or mode of action remains r, complex
picture with a disturbance of the biochemistry of hemopoietic tissue the basis
of the pathogenesis.
CLINICAL PICTURE
The onset may be sudden with general
malaise, high fever , chills, rapid pulse and
often stomatitis . The patient may then
have relatively few symptoms except for
prostration and fatigue. During this stage
leukopenia results, particularly granulocytopenia. The patient may then become
jaundiced, have gangrenous ulceration of
the gums, tonsils, soft palate, lips, pharynx
or buccal mucosa. Less frequently the
skin, nose, vagina, uterus, rectum or anus
are involved. There may be splenomegaly.
Infection soon develops, due to lowered
resistance in the absence of granulocytes.
Bronchopneumonia or a septicemia usually
causes a fatal termination .
Recurrent or cyclic cases have been
recorded in which the acute attacks have
been followed by asymtomatic intervals
of weeks or months with an essentially
normal leukocyte count. After the second
or third attack the outcome is usually
fatal. In the so-called "chronic" cases, the
periods of a relatively normal leukocyte
count are followed by attacks of malaise,
headache, dizziness, fatigue and prostration but may occur without fulminating
angina.
Laboratory Findings

( 1) Blood Picture
The predominant finding is that of
granulocytopenia but an associated decrease of the other leukocytes is usually
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---Agranulocytosis------------------found. In acute cases, the count is initially
less than 2000 per cu.mm. and then frequently drops to less than 1000 per
cu.mm. Cases have been recorded with
white counts as low as 50 and a complete
absence of granulocytes. The granulocytes may have a pyknotic nucleus with
vacuolated cytoplasm containing poorly
stained granules. The presence of myelocytes in the blood only occurs after recovery begins. The lymphocyte is the predominating leukocyte found in the blood
smear; occasionally, a relative increase in
the monocytes is observed.
In the recurrent or cyclic forms of
agranulocytosis, the leukocyte count rarely
drops below 2000 per cu.mm. and the
granulocytopenia is less pronounced.
In the typical case there is no anemia
or thrombocytopenia, and the bleeding
and clotting times are normal. There is
no variation in appearance of the erythrocytes or in the reticulocyte count. However, the sedimentation rate is greatly elevated and the icteric index may be
increased .
(2) Bone Marrow

The examination of the bone marrow
shows normal erythropoietic tissues with
a normal number of megakaryocytes. The
microscopic picture may be one of moderate hypoplasia or of hyperplasia. The
outstanding feature of the marrow is the
lack of granulocytes which include not
only polymorphonuclear cells but also the
metamyelocytes and the myelocytes. An
increase in the plasma cells, lymphocytes
and reticulum cells may be seen but is not
striking.
(3) Urine

There may be a trace of albumin but
the urine is otherwise normal.
( 4) C11/tures

Blood cultures are often positive for
a great variety of organisms. The current
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optmon is that these are secondary invaders due to the lowered tissue resistance
in the absence of granulocytes.
Blood cultures often contain upper
respiratory organisms.

DIAGNOSIS
The early symptoms of agranulocytosis
simulate many other conditions so closely
that it is often difficult to diagnose the
condition before a septicemia has developed. It is essential that a physician
be aware of the condition when any drug
known to produce agranulocytosis is used
and he should therefore be suspicious of
any unusual symptoms. White blood cell
counts should be done on these patients
receiving the drug at least twice each
month during therapy.

DIFFERENTIAL DIAGNOSIS
When local symptoms in the buccal
cavity or a pharyngitis are present it is
essential to differentiate the cause. In the
majority of infections of the ' oral cavity
and pharynx, leukocytosis is found . In
other conditions such as typhoid fever,
rubella, rubeola and undulant fever that
present a leukopenia, the more gradual
onset, and the characteristic signs and
symptoms distinguish them from agranulocytosis. In any condition with a leukopenia it is unlikely that the leukocyte
count would reach as low a level as found
in this particular disease.
Some of the blood dyscrasias present a
leukopenia; acute "aleukemic" leukemia
and aplastic anemia can be recognized by
the appearance of an anemia and thrombocytopenia. Leukemia often presents with
immature leukocytes in the blood and
adenopathy and splenomegaly. In infectious mononucleosis, extreme leukopenia
is unusual; the lymphocytes are atypical
and there is a positive heterophil antibody test (Paul-Bunnell Test).
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PROGNOSIS
Before the advent of sulfonamides and
antibiotics, the mortality in agranulocytosis was between 75 - 90 per cent and
was greatest in elderly patients. The outcome is very poor if the patient becomes
drowsy, confused, has profound prostration , jaundice, necrosis of the skin and a
leukocyte count below 1000 cu.mm . with
the absence of all granulocytes.
Death usually occurs from secondary
complications such as sepsis, pneumonia
or hemorrhage following necrosis.
Any improvement in the condition is
manifested by the appearance of leukocytes of the granular series in the blood;
myelocytes are the first to appear and
then the metamyelocytes with myeloblasts
on occasion. The segmented neutrophils
are the last to appear. The appearance of
monocytes that persist is thought to be
a favorable prognostic omen . The leukocytic reaction may be marked and rapid
with a leukocytosis of 15,000 per cu.mm.
most often found.
MANAGEMENT
The actual management is difficult because many cases are extremely ill before
any treatment is initiated or the patient
is dead before any benefit can be derived.
In many cases more than one remedy is
used and so it is often difficult to evaluate which one actually produces a beneficial effect. Some observers report good
results with certain drugs but other investigators have not been able to reproduce their findings .
A . Prophylaxis
The most important single factor in
the treatment is caution in the use of any
drug or related drugs capable of producing agranulocytosis. If the drug has been
proven to cause the condition, the physician should be on the lookout for any
leukopenia while the treatment is being
MARCH,
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carried out. The drug (or drugs) should
be immediately stopped if granulocytopenia presents itself. The structural formula should be examined and if the substance contains one or more " benzamine"
groupings, the possibility of agranulocytosis should be seriously considered.
B. General Care
Symptomatic treatment is essential and
of great importa-nce. The diet should be
adequate with a liberal vitamin supplement. The possibility of any secondary
infection should be minimized. The mouth
and any local lesions should have meticulous care. The mouth and throat may
be sprayed with a saturated solution of
potassium chlorate; the ulcerated areas
may be swabbed with a solution of copper
sulfate ( o.65 gms. to 30 c. c.) .

C. Specific Treatment
1. Antibiotics and Sulfonamides

The use of antibiotics is perhaps
the most beneficial specific agent. Penicillin is of great assistance in preventing an
overwhelming sepsis. The actual reappearance of granulocytes probably occurs spontaneously after the offending drug has
been removed . Although the sulfonamides have been known to cause agranulocytosis, they should not be withheld if
they are not the offending agent. With
the advent of penicillin and the broad
spectrum antibiotics, however, it is seldom necessary to use the sulfonamides.
2. Nttcleic Acid Derivatives

Of prime importance in agranulocytosis is the stimulation of granulocyte
production . Compounds such as sodium
nucleinate or pentonucleotide are no
longer in use.
3. ACTH and Cortisone
These hormones have been reported to hasten recovery in some cases.
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---Agranulocytosis------------------Their use is based on the possibility of a
hypersensitivity reaction being involved in
the pathogenesis. They constitute a doubleedged sword, since they further depress resistance to infection. Antibiotic coverage
must be maintained while the patient is
being treated with either hormone. A
satisfactory dosage is 50 mgm. of cortisone orally or intramuscularly four times
daily, or 20 to 30 mgm . of ACTH by
slow intravenous drip during an eight
hour period each day.
The danger of using ACTH and cortisone must be weighed carefully in each
case against the possible but uncertain
beneficial effect on the agranulocytic
process.

4. Bone Marrow
Yellow bone marrow and marrow
extracts have been given orally with the
hope of containing a marrow stimulating
factor. The actual benefit produced has
been questionable although the originators of this treatment report promising
results.
5. Blood Transfusions
Transfusions of normal whole
blood, blood from patients with leukemia
or leukocytosis have been used, but with
inconclusive results.

6. Liver Extract
Large doses of liver extract given
intramuscularly have been used in an
attempt to overcome any anemia present.
The actual leukocyte formation (if any)
has not been clearly demonstrated.
7. Splenectomy
Splenectomy has been recommended in some c h r o n i c cases of
agranulocytosis.
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8 . British Anti-Lewisite

Where the granulocytopenia has
been produced by arsenic or gold, B.A.L.
has been given in doses of 1.5 mls. of a
10 per cent solution in oil six times daily
for the first two days and then twice
daily for another 8- 10 days. B.A.L. has
a pronounced beneficial ·e ffect in heavy
metal poisoning and it is on this assumption that the substance is given in the
treatment of this condition.

Conclusion
Many other measures have been tried
in the treatment of agranulocytosis but
most have seemed irrational. When the
precise etiology has been discovered, then
a specific form of treatment may be made
available.
It must be emphasized that prophylaxis
is the best "cure" and that drugs known
to cause this condition should only be
used as a calculated risk.
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Bleeding Disorders
D. B. MELTZER, B.Sc., M.D., F.R.C.P. (C)

INTRODUCTION
Bleeding disorders are uncommon, but it is most important that they be
recognized as such . Recognition may lead to diagnosis, and this in turn to an
available treatment; above all, recognition may forestall tragic complications of
surgery ''bleeders'' are always poor surgical risks. A great deal has been
learned about the mechanisms of blood coagulation since the classical theories
were proposed . To the average physician this newer knowledge appears to be
very complex ; however, on further careful study it becomes apparent that the
mechanisms of the various "bleeding" disorders are much better explained on
the basis of this newer knowledge. Therapy based on replacement of demonstrable defects is daily becoming more effective.
One great difficulty in understanding blood coagulation, and even in reading
about it, is terminology . Each factor has several names, and in at least one instance a single factor has been needlessly separated into two. The situation is fortunately ever more hopeful in that a more orderly pattern is evolving, and almost
every month another piece of the puzzle is put into place.
It is not the purpose of this paper to elucidate the mechanism of blood
coagulation, but rather to present a small amount of working theory, and to
attempt to apply this to some of the more simple investigative techniques, with
a view to the "screening" of bleeding problems.

The classical scheme of coagulation is
of course rendered inadequate by present
day knowledge, but it still serves as a use. ful framework upon which to build the
more complex structure which is constantly being elaborated. There are three
main steps:
foreign surface -+ thromboplastin (i.e. the generation of thromboplastin)

1. Platelets

+

+ prothrombin +
Ca+ + -+ thrombin (i.e. generation
of thrombin)

2. Thromboplastin

3. Thrombin + fibrinogen -+ fibrin
(clot) (i.e. generation of fibrin).
Ordinarily this system of coagulation is
held in abeyance, but when need arises
it must become active and reach its purposed end quickly, perform its function,
then bow out. The newer factors described
help to explain how this is possible, how
the clotting starts slowly, then accelerates, and finally that a clot does not
MARCH,
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propagate infinitely. The normal person
is able to set up such a system of defence
against bleeding which will protect him
from all but the major injuries to blood
vessels.
Vascular and Platelet Factors
It is apparent that when a tissue IS mjured, with laceration of blood vessels, a
mechanism for hemostasis must be put
into operation at once. The initial reaction of the blood vessels in the damaged area is constriction, which is mediated by axon reflexes f rpm the noCIceptive stimulus. The effect is to slow
up the local circulation, and this may aid
in the agglutination of platelets. The
tissue injury also leads to liberation of
thromboplastic substances. The agglutination of platelets leads to the release of
a vasoconstrictor substance (angiotonin)
which causes a generalized vasoconstric ·
tion to the area, and also to the release
of thromboplastic substances and acceler-
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---Bleeding Disorders,----------------ator factors of coagulation. The platelet
and tissue factors form thromboplastin
and a system is set up which results in a
mechanical plug (clot) at the site of blood
vessel injury. The clot eventually retracts,
completing temporary hemostasis. Per·
manent hemostasis involves the organization of the clot, and its eventual removal
( fibrinolysis) and recanalization of the
blood vessel, with laying down of a new
endothelial lining.
In discussing the vascular factors, it is
apparent that despite any coagulation defect , if the vascular wall be intact spontaneous bleeding cannot occur. The corollary is also true, that with a perfectly
normal coagulation system, but with a
blood vessel wall defect spontaneous
bleeding can , and does, occur. These vascul ar factors are understood only poorly.
They include an intracellular cement substance, collagen fibres, fibrous tissue, endothelial lining, and neuro-humoral control. Scurvy is a good example of such
a defect, in which ascorbic acid is insufficient for maintenance of the ground substance. A similar defect is probable in
senile purpuras. Congenital defects of the
small blood vessels probably explain the
hemorrhagic diathesis of "vascular pseudohemophilia" (Von Willebrand's disease), and hereditary hemorrhagic telangiectasis, idiopathic hematemesis, and
melena. In " primary" pulmonary hemosiderosis there is said to be an immunohematolog ical factor .2 It is postulated
that the defect is in contractility of the
vessels in the latter group of diseases.
It is of great interest that primary pulmonary hemosiderosis and " vascular pseudohemophilia" manifest as episodic bleedi~g, with intervals in which bleeding
times are normal.
Hypertensive individuals may also show
purpura. Here there are several factors
at play ; frequently there is a defect of
the walls of the arterioles, increased pressure opposes contraction and promotes
flow through a defect. Such people may
have a positi ve tourniquet test.
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Inspection of the skin and mucous
membranes in hereditary hemorrhagic telangiectasia shows dilated capillary and
arteriolar loops which can be emptiedobviously if one of these is injured it is
incapable of contracting sufficiently, and
therefore prolonged bleeding ensues. In
"vascular pseudohemophilia", by using
special but simple techniques, one can see
under the microscope the tortuous capillary loops in the nail beds (in vivo)}
The diagnosis of these two disorders thus
can be made quite easily if one takes an
adequate personal and family history, and
completes a few simple tests. The treatment of these congenital disorders has,
to date, been unsatisfactory. Local pressure, if possible, is the best means of
achieving hemostasis ; as an alternative,
cautery may be used. Diagnosis is, however, most important in order that necessary precautions may be exercised.
Thrombocytopenic purpura is a more
complex situation, involving both vascular
and coagulation defects. It is possible
that some hormonal control exists in this
situation since adrenal steroids and ACTH
will usually control the purpuric manifestations without necessarily improving the
platelet count.4 As was mentioned above
the platelets, in addition to having a~
angiotonic effect, apparently release a
thromboplastin precursor and possibly an
accelerator of prothrombin conversion,
and of fibrinogen conversion ; as well they
appear to release an "anti-heparin" subs~ance . It is apparent then, that qualita·
tl.ve ~s well as quantitative platelet defioenoes may affect clotting. In thrombocytoasthenia (Glanzman's disease) there
are normal numbers of platelets, but
these are of bizarre morphology and are
deficient in function .
Platelet deficiency manifests itself in
several ways :
1. Purpura (i .e. spontaneous bleeding

into skin and mucous membranes)
2.

Prolonged bleeding time
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3. Poor clot retraction

The second phase (still a slow phase)
depends
upon the production of throm4. Diminished prothrombin consumpboplastin,
which interacts with prothromtion
bin, calcium, labile and stable factors to
5. Positive tourniquet test
form thrombin. If there is failure of formation of adequate thromboplastin little
6. Poor fibrinogen conversion.
thrombin will be formed, i.e. prothrombin will not be sufficiently used up and
Plasma and Serum Factors
will remain in higher than normal levels
There are present in the plasma several in the serum. This is the basis for the
important coagulation factors. These may prothrombin consumption test, i.e. the
one stage prothrombin time of the serum
be divided into three groups:4
is measured, using an exogenous source
1. Thromboplastin antecedents
of fibrinogen. A diminished prothombin
·consumption, then, indicates a defect in
(a) Antihemophiliac globulin
phase one; thus it is a good screening
(A.H.G.)
test for the hemophiliac diseases, and for
(b) Plasma thromboplastic com pon- platelet deficiencies. This test can be carent (P.T.C. or Christmas factor)
ried out in any hospital laboratory.
(c) Plasma thromboplastic anteDefects of the second phase show up
cedent (P.T.A.) - and probas
a prolongation of the prothrombin
ably several others
time. This finding usually indicates de2. Prothrombin, calcium and fibrino- liberate anticoagulation, or acquired hypogen
prothrombinemia from liver disease. It
is
also seen in association with obstruc3. Accelerator factors (labile and stable
tive jaundice. Defects of labile and stable
factors)
factors also affect the prothrombin time,
As well, there is a system controlling the and one can usually deduce which factor
lysis of clot, which will be discussed later. is at fault by adding fresh plasma, stored
plasma and serum .
All of the above are present in the
serum except fibrinogen, in concentraThe third (accelerated) phase of cotions related directly to their utilization agulation involves acceleration of the reduring coagulation; there is also a stable actions just described, and pari passu
component, serum accelerator, thrombin, reaction between fibrinogen and throm(and an inactive, but potentially active, bin to form fibrin clot, with the aid of
metathrombin complex).
a platelet factor (Platelet factor No. 2).
Coagulation Theory
To discuss coagulation per se, there
are three phases, as is mentioned in the
classical theory. The first phase, a slow
phase, involves platelet and tissue factors
plus the plasma thromboplastin antecedents interacting to form thromboplastin. Defects in this phase are detectable by the thromboplastin generation test; this test, however, is not within
the compass of the average laboratory.
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This whole reaction is autocatalytic, thus
ensuring abundant factors. It appears
that the basic trigger is the formation of
a small amount of thrombin, which thus
acts upon platelets, labile, and stable factors. It is apparent that once such an
autocatalytic agency is set up, there must
be "some way of stopping it", lest a complete clotting of the vascular tree occur.
Owren has postulated an inhibitor substance against labile and stable factors.
Fibrin clot actively removes thrombin,
thus the main cog of the autocatalytic
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---Bleeding Disorders----------------mechanism is removed at an ever increasing rate until further fibrin formation
must cease. The thrombin is later released at a slow rate so that it can be
inactivated by anti-thrombin substances.
Meta·thrombin is the name given the reversible end product of the absorption of
thrombin by this group of substances.

quickly diminish abnormal fibrinolytic
activity. This phase of coagulation is
mentioned because a severe bleeding diathesis may ensue from excessive fibrinolytic activity. This occurs in "stress" situations, hemorrhage, trauma especially to
lungs, shock, extensive surgery, leukemia,
and with carcinoma of prostate.

Antithromboplastic Substances

Screening Procedures

Antithromboplastic substances are receiving prominent notice in the newer
literature) Tocantins has postulated that
an antithromboplastic substance excess is
the fault in hemophilia, rather than a deficiency of A.H.G., as is postulated by
most other coagulationists. Another, but
entirely different, thromboplastin inhibitor may develop in association with a
variety of conditions:

In screening a possible bleeding problem it is advisable to proceed stepwise,
and to think, as much as possible, of the
various phases of coagulation. There are
a number of relatively simple laboratory
tests which are of considerable help, if
properly carried out and correctly interpreted . I shall attempt to describe these
tests briefly, and to mention some of the
other pertinent tests.

1.

Multiple transfusions (especially in
hemophiliacs)

2. Pregnancy with an Rh incompatible

product
3. Pemphigus
4. Lupus erythematosus disseminata
Etcetera.
In such situations there may be a resultant severe hemorrhagic diathesis.
Fi'brinol ysis
Once the clot is formed, it must of
course be removed after it has completed
its function; this is brought about by a
fibrinolytic system.5 The circulating plasma carries profibrinolysin, which may be
activated by bacterial filtrates (such as
streptokinase) and by normally occurring
tissue fibrinolysokinase ( which is particularly abundant in lung and uterine
tissue). The active end product is fibrinolysin, which are inhibitors of clot lysis.
The mechanism appears to have at least
some endocrine control, in some way
mediated through the pituitary gland, indeed ACTH or adrenal steroids may
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The history obtained from the patient
is not a laboratory procedure, but it is a
most important aspect of the investigation of a bleeding problem. One should
enquire specifically about bruising tendency, bleeding from nose and gums,
stools, urine, excessive bleeding from
small".abrasions, etcetera, and in females,
menorrhagia. The family history is of
great importance, as "bleeders" are usually
well known in a family group, and it
is important to know the sex of the
"bleeders" and whether they are of maternal or paternal lineage.
Cases with a family history of both
male and female bleeders (usually mild)
whose only demonstrable defect of coagulation is a prolonged (variably so)
bleeding time, and whose bleeding can
be arrested only by local pressure, fall
into the group of hereditary purpuras
entitled "vascular pseudohemophilia" or
Von Willebrand's disease. The diagnosis
is confirmed by examination of the nail
bed under oil and using a blue lightthe characteristic tortuous arterioles are
readily observed. This disease illustrates
the importance of using standard tech-
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niques for even such a "simple" test as
a bleeding time. The Ivy technique6 is
a useful standard, and lends itself to comparisons. In this technique a manometer
cuff is placed about the upper arm and
inflated to 40 mm. of mercury maintained
at that level, an avascular area on the
volar surface of the forearm is selected
carefully cleaned with alcohol, and al~
lowed to dry. With a sharp scalpel blade,
a cut is made 2 mm. deep and 2 mm.
long, and at this moment a stop watch
is started . At 30 second intervals a piece
of filter paper is lightly placed over the
cut. In this way a permanent record is
made. When no more blood attaches to
the filter paper the bleeding time is
recorded . The normal value varies from
one-half minute to 6 minutes. This method
is recommended over the Duke (ear lobe)
method for 3 main reasons :
1.

Permanent record is obtainable

2. It is standardized for venous pres-

sure, and also for depth and size
of the cut
3. Bleeding is easily controlled in this
area (and in true bleeders this may
be very important.
Prolongation of the bleeding time is seen
in cases with a defect (primary) of the
vascular wall, as in "pseudohemophilia",
scurvy, and as well in cases with a secondary defect such as in thrombocytopenia and thrombocytoasthenia.
With the manometer cuff still in place
as for the above test, one may carry out
the tourniquet test for capillary fragility.
In this procedure the forearm is carefully inspected for skin lesions which
might be confused with petechiae, then
the manometer is inflated to half way
between the systolic and diastolic pressures and left at this level for 5 minutes
(or up to 10 minutes if the patient can
tolerate this). Various methods of recording the test are used; commonly, an area
the size of a twenty-five cent piece is
selected about 3 em. below the antecubital
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fold. A count of petechiae is made in
this area after the pressure has been released for 2 minutes. Any count above 5
is significant in men, above 10 in women.
This test is positive in scurvy, senile purpura, and in thrombocytopenia when the
platelet count is below 70,000 by the
Dameshek method or 35,000 by the direct
method.
The clotting time of whole blood is a
procedure readily carried out in the office
or at the bedside. It should be done carefully in ordet to avoid as many variables
as possible.7 Four clean dry test tubes
2Yz " x %" are used, a clean venipuncture
is made with a sharp # 19 gauge needle,
and a small quantity of blood is withdrawn. The tourniquet is then removed,
a paraffined or siliconized syringe is attached to the needle, and 4 cc. of blood
are withdrawn gently, at which time the
stop watch is started . 1 cc. of blood is
placed into each test tube, and these are
kept at body temperature, preferably in
a water bath, but if need be, this can be
in a shirt pocket. The tubes are tilted at
V2 minute intervals, and the clotting time
of each is that point when the clot holds
together when the tube is inverted . The
clotting time is the average of the four
tubes. Normal value by this method is
5 to 10 minutes for ordinary tubes, and
18 to 25 minutes with siliconized test
tubes. The latter is the more sensitive
test, and detects a coagulation defect more
readily this is especially so in the
hemophiliac group of diseases . These
samples may be further used, for the prothrombin consumption test, or they may
be left in a water bath at 37° C. for 24
hours for investigation of clot retraction
and fibrinolysis. Of course, the observation of the clot gives at least some idea
of the adequacy of the fibrinogen level.
The clotting time is usually abnormal in
the hemophiliac group, in cases with
idiopathic or induced anticoagulants, extreme fibrinolysis, and in cases with gross
deficiencies of prothrombin and its allied
accelerators.
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---Bleeding Disorders----------------The second phase of coagulation is observed by the estimation of plasma prothrombin. This can be carried out in an
office, but very few offices have the
necessary equipment; however, it should
be available in any clinical laboratory. It
is not within the scope of this paper to
discuss anticoagulant therapy, but it must
be realized that this test is important in
screening bleeders. Elevated prothrombin
times are of course most commonly seen
in anticoagulant therapy with coumarin
derivatives (and it must be re:tlized that
these drugs may be taken unwittingly,
for the purpose of malingering, or even
with suicidal intent) . In severe liver disease there may be a diminished prothrombin level (and also of factor VII)this need be only slight to be of significance. Owren has described a bleeding
diathesis caused by labile factor deficiency
in which an alteration in prothrombin
time is demonstrable. In obstructive jaundice, because of the poor absorption of
vitamin K, there is an elevated prothrombin time, which can be corrected by
parenteral administration of vitamin Kand indeed this may be a useful test of
liver function and a tool in the differential diagnosis of jaundice. In hemorrhagic
disease of the new born there is a prolonged prothrombin time which can be
corrected by parenteral administration of
vitamin K. The exact mechanism of this
defect has yet to be elucidated, but it does
appear that the prophylactic use of vitamin K has cut down the incidence of
this disease, so presumably there is a defective absorption of vitamin K rather
than poor utilization of it.
To backtrack for a moment to the first
phase of coagulation, this phase is observed by the thromboplastin generation
test 8 which is not easily carried out, and
by the prothrombin consumption test9
which is readily performed. In this latter
test, blood is allowed to clot under standard conditions, and after a set period of
time the prothrombin level of the serum
is measured . Thus if thromboplastin is
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deficient, prothrombin will not be consumed to a normal extent in clotting, and
hence will remain at high levels in the
serum. This test then is abnormal in diseases with quantitative and qualitative defects of platelets, and in the hemophiliac
group of diseases.
The platelet count may be difficult to
perform in the office or even in a laboratory where it is an infrequent test, but a
good substitute is the examination of a
carefully made and well stained blood
smear, preferably on matched coverslips.
Ordinarily one sees one or several platelets in almost every oil immersion field,
whereas in thrombocytopenia, several
fields must be viewed before a single
platelet is observed. The smear also permits morphological study of the platelets.
Thus the stained blood film is an important, and easily carried out, screening
test.
Fibrinogen estimations are difficult, but
observation of the clot is helpful, and
more recently a simple screening test for
fibrinogenopenia has been made available
commercially-this is called "Fibrindex"and should prove to be very useful and
time saving.
Because of the recent publicity about
hemorrhagic diathesis in association with
fibrinolysins,~ I shall make brief mention
of this subject. Fibrinolysis is seen in
many circumstances such as:
1. Pregnancy
2.

Hemorrhagic shock and trauma
(especially to chest)

3. Extensive surgery (again especially
to chest)
4. Premature separation of placenta
(here there is another mechanism
of intravascular clotting because of
thromboplastic embolization in many
instances).
5. Leukemia
6. Liver disease, especially cirrhosis
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7. Transfusion reactions
8. Metastatic carcinoma of prostate.
The detection of fibrinolysis is exceedingly simple. A sample of blood is left
to clot in a clean dry test tube at 37° C.
for 24 hours, and is observed at regular
intervals. If there is lysis of the clot before the end of 24 hours, there must be a
fibrinolysin present. If, on the other
hand, no clot forms, there must be complete afibrinogenemia, or a circulating
anticoagulant. If the latter be the case,
addition of this person's plasma will prolong the clotting time of normal whole
blood.

Comment
This discussion has of needs been rambling. I have attempted to deal with the
generalities of blood coagulation, with a
view to clarifying some of its "mysteries",
and to present what is, I hope, an easy
plan for use in screening "bleeders". To
recapitulate, the history re personal and
family bleeding tendencies is all important. The bleeding, clotting, and prothrombin times (of both plasma and
serum), examination of a well stained
blood film, and observation of the clot,
are some of the important laboratory
steps. If the findings are properly inter-
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preted, one can determine at least whether
or not a bleeding problem exists, and possibly why it exists and what can be done
about it.
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Hetnophilia
and the Related Disorders
MERVYN LAKIN, Meds '56

INTRODUCTION
Hemophilia has been defined as a clinical disorder characterized by a tendency
to bleed and by a prolonged clotting time of whole blood which is strongly
familial and is almost exclusively present in males. Our increasing knowledge of
the mechanism of the coagulation of blood has led to the discovery of syndromes
almost indistinguishable from classical Hemophilia, but which are amenable to
differentiation and characterization by special laboratory studies. This paper is
intended to discuss classical Hemophilia, which shall arbitrarily be referred to as
Anti-hemophilic globulin (AHG) deficiency, Pl asma Thromboplastin Component
(PTC) deficiency or " Christmas Disease," and Pl asma Thromboplastin Antecedent
(PTA) deficiency.

PATHOLOGICAL PHYSIOLOGY
Two major theories have been advanced
to explain the etiology of the bleeding
in Hemophilia and the related disorders.
The first, and more widely accepted
theory, states that Thromboplastin requires for its formation platelets, calcium,
AHG (thromboplastinogen), PTC, and
PTA. With dassical hemophilia, the
AHG which is required for thromboplastic activity is missing, deficient, or
defective. It has been postulated recently
that AHG must be activated by thrombin
before it will react with platelets. Since
thrombin is directly or indirectly responsible for the disintegration of platelets,
and since in this condition only a minute
amount of thrombin is formed , the platelets remain intact and defective hemostasis results. Similarly, the deficiencies
of PTC and PTA will cause defective
hemostasis. The varying degrees of severity can be accounted for by different degrees of insufficiency of these components.
The second theory has been postulated
by Tocantins . He believes that thromboplastin formation requires two components: a cephalin-like lipid factor con-
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tained in platelets; and a plasma factor
in the form of a conjugate of a platelet
co-factor with a lipid inhibitor. He visualizes that the platelets are disrupted
releasing the cephalin-like lipid and that
the co-factor/lipid inhibitor conjugate is
dissociated. The interaction of these components causes the formation of a cephalin-like lipid /co-factor conjugate which is
plasma thromboplastin . If there is a disproportionate increase in the lipid inhibitor conjugated with the plasma cofactor of platelets, the amount of platelet
material available is insufficient to overcome the excess of inhibitor and the
interaction of platelet lipid and its plasma
co-factor is prevented or greatly slowed,
causing little plasma thromboplastin to be
formed. This, Tocantins believes, is the
fundamental defect of classical Hemophilia. According to this theory, various
degrees of excess of the antithromboplastin activity above normal, result in the
different degrees of severity of the condition. If there is a disproportionate
decrease in platelet plasma co-factor with
which the lipid inhibitor is conjugated,
slower than normal thromboplastin formation results. This may explain the
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pathogenesis of PTC deficiency since
Tocantins believes that the platelet cofactor is probably PTC. Here, too, one
gets various degrees of severity due to
various degrees of insufficiency of the
platelet co-factor.
GENETICS
Both Hemophilia and PTC deficiency
are hereditarily similar. The trait is transmitted as a sex-linked recessive characteristic carried by the female and transmitted
to the male. The gene is located in the
X chromosome. If a hemophilic male
(XY) marries a normal female (XX), the
genotypes of their children will be XX,
who will be female carriers, and XY, who
will be normal males. If a normal male
(XY) marries a hemophilic carrier female (XX) , the genotypes of their children will be as follows: XX, a normal
female; XX, a hemophilic carrier female;
XY, a normal male ; and XY, a hemophilic male. It i.:_ possible that if a
hemophilic male (XY) marries a carrier
female (XX) , one of their children may
have a genotype of XX, which would
make her a hemophilic female . Such cases
have recently been reported.
Only 50-75 % of hemophilics give a
family history of the disease. The reasons
for this are threefold: first, an inadequate
or inaccurate history may have been obtained; secondly, only female children
may have been born for several generations ; and finally, some consider that a
gene mutation might occur in which the
normal gene becomes a hemophilic gene.
PTA deficiency is transmitted as an
autosomal, dominant trait. The disease
may be transmitted by either males or
females to male or female progeny.
PROPERTIES
Different fractions of the blood produce various findings with respect to
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AHG, PTC, and PTA activity. The
plasma fraction contains all three factors .
Normal serum does not contain AHG,
but does contain PTC and PTA. The
AHG activity is greatest in Cohn fraction I, whereas both PTC and PTA
activity are greatest in fractions III and
IV-1. Barium sulfate treated normal
plasma and Seitz filtered normal plasma
show both AHG and PTA activity but
no PTC activity. Fractional separation of
normal plasma by ammonium sulfate
shows that AHG activity is greatest in
the 0-25 % fraction , while PTC activity is
greatest in the 33-50% fraction, and PTA
in the 25-33 % fraction.
It is of great importance that AHG is
consumed in the clotting process while
PTC and PTA are not consumed, but
rather appear to be potentiated by the
clotting process and storage.

Differentiation of the various deficiencies may be carried out by mixing various
fractions with the plasma of the propositus and noting the effect on the clotting time of recalcified plasma. For example, stored plasma will correct the
clotting defect of PTC and PTA deficient
plasmas but will not correct the clotting
defect of AHG deficient plasma.

LABORATORY FINDINGS
Classically, Hemophilia is described as
having a prolonged clotting time of whole
blood. The other deficiencies also show
a delay in clotting. The majority of cases
with a clotting time of over 30 minutes
and especially over 50 minutes have AHG
deficiency. The majority of cases of PTC
and PTA deficiencies have a clotting time
of less than 30 minutes. Mild examples
of these deficiencies may show a clotting
time that is not prolonged. The prothrombin consumption test of Quick
which estimates the available thromboplastic potency of the blood, shows that
the prothrombin consumption is poor.
Similar findings are found with PTC and
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---Hemophilia and the Related Disorders--------PTA deficiencies for this test. Here, too,
very mild cases may present with an almost normal prothrombin consumption.
Several other tests have been shown to
be abnormal with classical hemophilia.
They are listed below.
1. Heparin clotting time is delayed.
2. Dilution

clotting times are pro-

longed .
3. Recalcified plasma clotting time by
either fast or slow centrifugation is
increased.
4. Bleeding time for deep cuts (5 mm.
or greater) is increased.
5. Thromboplastic activity test of Quick
is positive.
The Thomboplastin Generation Test is
a very sensitive test for deficiencies of
AHG, PTC, and PTA. The th ree conditions may be distinguished readily by this
test, as a rule.
Factors in the blood which are found
to be normal in value are as follows:
1. Bleeding time of shallow cuts.
2. Capillary fragility as shown by the

tourniquet test.
3. Clot retraction.
4. Platelet count.
5. Prothrombin level of plasma.
6. Fibrinogen level of plasma.
7. Calcium.
8. Accelerator globulins.
9. Serum Prothrombin Conversion
Accelerator (SPCA).
Tests for naturally occurring
coagulants are negative.

anti-

CLINI'CAL PICTURE
The principal manifestation of these
conditions is the presence of a bleeding
tendency. The bleeding is usually of a
slow persistant type lasting for days and
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often initiated by trivial injuries. The
bleeding tendency usually onsets early in
life. Hemorrhage at circumcision is often
the first sign. Later, bleeding or bruising
after minor cuts, injuries, or tooth extractions may be excessive or even intractable.
The manifestations and severity vary
from patient to patient but are often remarkably constant in any one person.
Some li ve almost normal lives with little
disability, while others, suffering from a
severe form , die at an early age. It has
also been shown that the degree of severity tends to be uniform throughout an
affected family.
AHG deficiency usually causes the most
severe bleeding tendency, while PTA deficiency usually has the least severe bleeding. There often seems to be some relationship between the degree of clotting
time increase and the severity of the
hemorrhage.
In AHG deficiency, it is commonly
found that repeated hemorrhages into
joints occurs with eventual production of
arthritis, deformity, and limitation of
movement due to formation of ankyloses.
In this condition subcutaneous and intramuscular hemorrhages are frequent and
often extensive and may be of a "spontaneous" nature. Hematuria may present
in some people. Less commonly, asymptomatic gastrointestinal bleeding is found.
Hemorrhage in the Central Nervous System is rare. Purpura is uncommon.
PTA deficiency seldom produces spontaneous bleeding. It is usually manifested
after trauma, surgery, or commonly dental extraction. Hemarthroses and purpura
are rare.
PTC deficiency lies in severity, between
AHG and PTA deficiencies. Hemarthroses here are also uncommon.
DIAGNOSIS
The classical triad for the diagnosis of
Hemophilia depended on three factors:
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1. The characteristic type of bleeding

beginning early in life.
2. The heredofamilial sex-linked trans-

mission practically limited to males.
3. Retarded coagulation reflected in
elevated clotting times and poor
prothrombin consumption.
It can be seen that the above factors
could not serve to differentiate AHG and
PTC deficiencies. The most sensitive way
of distinguishing these conditions involves
the use of the Thromboplastin Generation
Test. The final proof of the diagnosis of
any of these deficiencies depends on the
demonstration of the correction of the
clotting defect by various factors as
described above.

TREATMENT
Prophylaxis
The activities of the child who has a
tendency to bleed must be tempered as
much as possible. In adults, the patient
must learn to avoid strenuous exercises
and active participation in vigorous sports.
Injury, no matter how trivial, must be
guarded against.

General Measures
1. Diet-

There should be an adequate intake of
protein and Vitamin C.

shown that an AHG level of 1020 % of normal will assure adequate clotting. Fresh whole blood
transfusions provide a source of
AHG which will cause a temporary decrease in the clotting time,
lasting for several hours. It makes
no difference in the clotting time
if 100 cc. of blood is used or if
500 cc. is used. Fresh frozen
blood, reconstituted just before
use, provides adequate AHG levels. With severe bleeding, 100
cc. of fresh citrated blood every
6 to 8 hours may be given until
the hemorrhage is controlled .
With PTC and PTA deficiencies,
stored blood should be used in
preference since as stated above,
the effect of these substances
seems to be potentiated by clotting and storage.
(b) Plasma:
With AHG deficiency, fresh
whole plasma or reconstructed
lyophylized fresh plasma should
be used when the hematocrit is
normal or high. If there is danger of serious hemorrhage, it may
be necessary to provide a continuous supply of AHG by giving
plasma every 3 or 4 hours or by
a slow continuous IV drip. Once
again, it is preferable to use
stored plasma in the treatment of
the patient who lacks either the
PTC or PTA factors.

2. Pain-

Analgesics such as salicylates, codeine,
or demerol should be used to control
pain.
3. Agents used to control hemorrhage(a) Whole Blood :
Fresh whole blood is the method
of choice in the treatment of
AHG deficiency if the hematocrit
is low. In Hemophilia, it has been
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(c) Globulin Substances:
Plasma concentrates containing
AHG such as Cohn fraction I
may be given, but they are probably no better than simple transfusions since the body cannot
store AHG. Cohn fraction I is
of no value in PTC deficiency
and of questionable value in PTA
deficiency.
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---Hemophilia and the Related Disorders·--------(d) Local Hemostatics:
For the treatment of bleeding external surfaces, bovine thrombin
suspended in gelatin foam or
freshly formed fibrin is the hemostatic agent of choice. Powdered
tannic acid or powdered Russell
viper venom may be used, but
they are not as satisfactory.
4. Psychological Implications-

There must be a psychological readjustment on the part of the patient with
regard to the necessary restrictions of
activity. The readjustment must also
involve the mother of the patient because she may develop a guilt complex knowing that she transmitted the
disease to her child.
5. Special Consideratio1ts-

( a) External bleeding:
All the clot and other debris
should be removed by gentle
cleansing in order to get down
to the oozing area. If necessary,
the edges should be approximated,
but without sutures. Bovine topical thrombin should then be applied promptly and liberally to
the oozing area. A bandage
should be applied to exert moderate pr.essure. Bovine thrombin
should be used in preference to
human thrombin because of the
possibility of developing serum
hepatitis.
(b) Hemarthroses:
These should be treated conservatively. At first cold is applied directly to the joint which should
· subsequently be kept at rest. Concurrently, active treatment should
be undertaken to control the clotting defect. Later, heat may be
cautiously applied to absorb the
extravasated blood. Some people
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advocate aspirating the joint at
this stage with installation of
hyaluronidase into the joint cavity. A course of light massage,
passive exercise, and then gradual activated exercises should be
instituted to keep ankyloses at a
minimum.
(c) Carious teeth:
These are also best treated conservatively. They should be filled
in preference to extraction and no
local anesthetic should be used.
Teeth should only be extracted
for intractable pain. If extraction
is to be performed, the patient
should be brought into hospital.
A gutta percha or wax mold of
the mouth and gums !.hould be
made in order to produce pressure
around the tooth to be extracted.
After the extraction, the socket
should be dusted prophylactically
with powdered thrombin and then
the mold placed. Transfusions
may be considered .
(d) Surgery:
Surgery should be avoided as
much as possible. Septic conditions should be treated with antibiotics preferably, and cancer by
irradiation. If surgery is absolutely necessary, the patient should
be transfused before the operation
with the proper substances in
order to control the clotting defect. The transfusions should be
carried on at intervals until the
wound heals.
(e) Refractoriness to blood and
plasma:
Here, cortisone and ACTH may
temporarily diminish the refractoriness of the patient to blood
and plasma. Transfusions with
heparinized plasma may help also.
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Summary
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Abstracts
HEREDITARY SPHEROCYTOSIS
Can. Med. Association Journal,
January, 1956
John D. Stenstrom, M.D.
Hugh S. Ford, M.D.
The disease may be latent (the patient
being asymptomatic), mild, or severe, in
which case there is anemia, jaundice, and
exacerbations of acute crises. The basic
defect is the spherical shape of the red
blood cells which invites destruction by
the spleen, resulting in accelerated bile
pigment metabolism, hyperplastic bone
marrow, reticulocytosis, and anemia.
The spherocyte anomaly is an inherited
Mendelian dominant characteristic, transmitted by either parent. A diagnosis
should be made only when spherocytes
can be demonstrated in the patient, and
a parent, sibling, or offspring. Persistence
of spherocytosis and increased osmotic
and mechanical fragility are also essential characteristics.

lated to increased hemolysis, transient
marrow aplasia, and splenic effects on
the marrow.
The management of the crises as advised by some is multiple transfusions and
early splenectomy; others urge caution in
the use of transfusions because of severe
reactions. Some defer both transfusion
and splenectomy in hopes of a remission.
-Robert J. Tuttle, '56

ERYTHROBLASTOSIS FETALIS
Neva M. Abelson
Post graduate Medicine
Vol. 18, No. 4, October 1955
Two etiologic agents manifest as two
equally common forms of hemolytic disease of the newborn.

( 1) ABO Erythroblastosis:
The spleen is responsible for the rapid
elimination of spherocytes. Splenectomy
relieves the manifestations of the disease
although the basic defect remains. The
success of this operation depends upon
the removal of all splenic tissue.
Excessive bilirubin excretion leads to
the formation of gallstones in 75% of
cases. Bilirubinemia is seen without bilirubinuria. Hemoglobinemia and hemoglobinuria are not seen in uncomplicated
hereditary spherocytosis.
The pathogenesis of the crises in this
disease is unknown, but is probably re-
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One fourth of all babies possess erythrocytes that are incompatible with the
mother's serum, but the baby which develops hemolytic disease has group A
cells while the mother must have group
0 cells. The disease usually is mild, but
if the serum bilirubin approaches 20
mgm%, exchange transfusion with fresh
group 0 cells is indicated.

(2) Rh Erytbroblastosis:
One in seventeen Rh negative females
become sensitized during pregnancy.
Hemolytic disease may ensue.

U.W.O.

MEDICAL JOURNAL

Treatment
(1) Prophylaxis:

Every Rh negative female should have
three Rh antibody tests during pregnancy;
at 16 weeks (base line), 30 weeks and
35 weeks. Rising titer suggests hemolytic
disease.
In the event of intra-uterine death three
potential dangers confront the mother:
(a) emotional shock, (b) hypo-proteinemia as the result of rapid polyhydramnios and (c) disturbances of coagulation
with possible serious hemorrhage.

(2) Definitive:

(a) interruption of pregnancy at the
37th or 38th week, if the husband is
homozygous, there is a history of incompatible blood transfusion and the anti Rh
titer is greater than 1:64. Exchange transfusion prevents kernicterus in the baby.
(b) normal delivery and immediate exchange transfusion with packed group
0 cells. This with re-exchange transfusion controls fetal blood volume and
anemia.
The criteria for exchange transfusion
is to seek justification for withholding it.
-Bill Hogg, '57

Clinical Cases
W. P. Barton, M.D., F.R.C.P. (C)
A thirty-eight year old white, married,
housewife with three children was referred to Victoria Hospital, London, for
treatment of leukemia. The patient indicated that she had not felt well for the
preceding .six months, during which time
her .conjunctivae and skin became yellow
and pallor was superimposed as well. The
urine had been perhaps a bit darker but
the stools had remained normal in color.
At age 16, this · patient had begun to
have bouts of jaundice which were painless. Eventually pain in the right upper
quadrant supervened and led to an operation on the gall bladder, at age 34.
Following this, jaundice continued to
occur sporadically but was painless. The
patient's father and brother gave histories
many bouts of painless jaundice.

or

On examination, there was fairly marked
pallor and mild icterus. There were no
fundal changes, no palpably enlarged
lymph nodes and no bone tenderness.
The spleen tip was palpable 9.0 em. be-
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low the left costal margin in the midclavicular line on quiet breathing.
Laborato.ry Examination
Hemoglobin-9.0 Gm. (N 12 · 16 Gm.)
White count-14,500 (N 5 - 10,000)
Reticulocytes-12.5% (N 0.5 · 1.0%) .
Examination of smear of peripheral
blood:
normal diff,.rential
many small dense red cells with no
area of central pallor: many large
cells
platelets numerous. .
.
Osmotic fragility of red cells-increased.
Diagnosis
Hereditary Spherocytosis.
Comments
This disease is comm·only called familial
alcholuric jaundice, which is less accur-
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---.Abstracts--------------------ate than the term hereditary spherocytosis
because some .of these patients do not have
jaundice and have only the mildest
anemia. The diagnosis can be suspected
by history and confirmed usually by
simply looking at a well-prepared smear
of peripheral blood.
Splenectomy is curative. The red cell
abnormality persists but the red cell survival time returns to the normal range
once the spleen is removed. If this procedure is carried out at a sufficiently
early age, it is likely that cholelithiasis
might be circumvented.

Examination of bone marrow:
Many megakaryocytes, few of which
were forming platelets. No abnormal
cells seen. Erythroid and granulocyte
series normal.

Diagnosis
Acute Thrombocytopenic Purpura (postinfectious measles).
Comment

Twelve-year-old girl was admitted to
hospital because of a generalized purpuric
eruption, ready bruising and epistaxes of
one week's duration.
Three weeks previous to admission the
patient and two siblings, as well as other
children at 3chool, had had measles.
On examination there were no abnormal findings except for the numerous
petechiae and bruises, which had no predilection for any particular area. The
spleen was not palpable.

Laboratory Examination
Hemoglobin 14.0 Gm.)
W.B.C. -

Platelets -

13.0 Gm. (N 12.0 -

8,500 (N 5 - 10,000)
26,000 (N 300,000).

Examination of smear of peripheral blood:
differential - normal
red cells
- normal
platelets
- rare.
Capillary fragility test - 3+
Bleeding time 20 min.
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Acute thrombocytopenic purpura is almost always a self-limited disease, which
requires no therapy unless active bleeding is in progress. Even then, splenectomy is not advisable.
This child made a quite uneventful recovery and, at the end of three weeks,
had a normal platelet count.

A twenty-eight year old white married
female was first seen at Victoria Hospital,
London, because of excessive uterine
bleeding, epistaxes and prolonged bleeding after a tooth extraction at age 26.
At that time her platelet count was found
to be in the range 50,000 - 80,000. In
the two years following her first admission she had bruised readily, but had not
had any alarming blood loss. Consistently during that time, her platelet count
remained subnormal. The bone marrow
was normal. The spleen was not palpable.
It was decided that definitive therapy
should be undertaken.
Accordingly, after pre-operative preparation with cortisone and transfusion with
blood from siliconized apparatus, splenectomy was performed.
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The spleen was of normal size and
microscopically showed no lesions. The
platelet count was normal within several
days and has remained so for a period
of 9 months.

By definition, spontaneous cure is rare.
Splenectomy offers a 70-80% chance of
cure. Why 20-30% fail to benefit from
the operation is not known, nor can one
predict in advance which patients will
respond.

Diagnosis

As a rule, cortisone or related adrenal
steroids will elevate the platelet count in
these patients while it is being administered, but the count reverts to low levels
on discontinuing the drug. A splenectomy seems to be a much more definite
measure and is without any of the unpleasant side effects of prolonged steroid
therapy.

Chronic idiopathic thrombocytopenia.

Comment
Chronic idiopathic thrombocytopenia is
a different disease from the acute form.
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List of Recent Accessions
December 1, 1955 to February 1, 1956
The Library of the Medical School contains about 50,000 volumes, all fully
catalogued, and is re~:arded as one of the best working collections of its kind in
Canada. It is particularly rich in complete files of the more important medical
journals. The books are on open shelves and students have access to all books and
current journals.

ANIMAL CULTURE
Asdell, S. A.: Cattle fertility and sterility. 1955.
BACfERIOLOGY
Burnet, F. M. : Principles of animal
virology. 1955.
BOTANY
Ainsworth, G. C.: A dictionary of the
fungi. 1954.
DENTISTRY
Johnson, A. L.: Dentistry as I see it
today. 1955.

Bicknell, F.: The vitamins in medicine.
1953.
Hamburger, F. : The medical care of
the aged and chronically ill. 1955.
Hunter, D .: The diseases of occupations. 1955.
International Neurochemical Symposium. Biochemistry of the develop·
ing nervous system. 1954.
McGill University: Prospect and retrospect in neurology. 1955.
Medlar, E. M.: The behavior of pul·
monary tuberculous lesions. 1954.
Oliven, J. F., Sexual hygiene and pathology. 1955.
Werner, S. C.: The thyroid. 1955.

GYNECOLOGY AND OBSTETRICS
Bowes, K.: Modern trends in obstetrics
and gynecology. 1955.
Brocq, P.: Atlas d'hysterographie. 1953.
Holland, E. L. : British obstetric and
gynecological practice. 1955.
HUMAN ANATOMY
Belt, E.: Leonardo the anatomist. 1955.
Brock, R. C.: The anatomy of the bronchial tree. 1954.
INTERNAL MEDICINE
Arieti, S.: Interpretation of schizophrenia. 1955.
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Williamson,
1955.

P.:

Office

procedures.

MEDICAL BIBLIOGRAPHY
Gacrison, F. H.: Gacrison and Morton's
Medical bibliography. 1954.
U.S. Library of Congress: Scientific and
technical serial publication, United
States, 1950-1953. 1954.
MEDICINE (GENERAL)
American Foundation: Medical research : a midcentury survey. 1955.
Guthrie, D.: From witchcraft to anti·
sepsis. 1955.
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Taylor, S. J . L. : Good general practice. 19:>4.

Rexford-Welch, S. C. : The Royal Air
Force medical services. v. 1, Administration. 1954.

NATURAL HISTORY
Arber, A.: The mind and the eye. 1954.
Oster, G .: Physical techniques in biological research. v. 1, 1955.
PEDIATRICS
American Academy of Pediatrics. For
the welfare of children. 1955.
PHYSIOLOGY
Veith, 1. : Perspectives m physiology.
1954.
Wynder, E. L. : The biologic effects of
tobacco. 1955 .
PUBLIC ASPECTS OF MEDICINE
Cope, Z .: The history of St. Mary's
hospital medical school. 1954.
SECOND WORLD
SERVICES

WAR-MEDICAL

SURGERY
Bick ham, W. S. : Surgery of the alimentary tract. 1955 .
Borgognoni, T .: The surgery of Theodoric, ca. A.D. 1267. 1955.
Cole, W . H .: Operati ve technic in general surgery. 1955 .
Henry Ford Hospital : International
symposium on cardiovascular surgery.
1955.
THERAPEUTICS
Ameri can Medical Association: Glandular physiology and therapy. 1954.
Hardy, J. D.: Fluid therapy. 1954.
Klaunberg, H . J. : Tea : a symposium
on the pharmacology and the physiologic effects of tea. 1955.

Hachiya, M .: Hiroshima diary. 1955.
Jeffcott, G. F.: United States Army
Dental Service in World War II.
1955.
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ZOOLOGY
Conference on Group Processes.
1954.

1st,
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